31 related articles for article (PubMed ID: 16879988)
1. The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis.
Aghajanova L; Velarde MC; Giudice LC
Endocrinology; 2009 Aug; 150(8):3863-70. PubMed ID: 19389829
[TBL] [Abstract][Full Text] [Related]
2. Effects of tibolone metabolites on human endometrial cell lines in co-culture.
Barbier C; Kloosterboer HJ; Kaufman DG
Reprod Sci; 2008 Jan; 15(1):75-82. PubMed ID: 18212357
[TBL] [Abstract][Full Text] [Related]
3. Effects of tibolone on nuclear receptors in human endometrial cells.
Zhang W; Mazella J; Kloosterboer HJ; Tseng L
Am J Obstet Gynecol; 2006 Jul; 195(1):97-102. PubMed ID: 16813748
[TBL] [Abstract][Full Text] [Related]
4. Effects of tibolone and its metabolites on prolactin and insulin-like growth factor binding protein-1 expression in human endometrial stromal cells.
Guzel E; Buchwalder L; Basar M; Kayisli U; Ocak N; Bozkurt I; Lockwood CJ; Schatz F
Gynecol Endocrinol; 2015 May; 31(5):414-8. PubMed ID: 25856298
[TBL] [Abstract][Full Text] [Related]
5. Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone.
Falany JL; Falany CN
Steroids; 2006 Oct; 71(10):880-5. PubMed ID: 16857224
[TBL] [Abstract][Full Text] [Related]
6. Tibolone and metabolites induce prolactin production in human endometrial stromal cells in vitro: evidence for cell-specific metabolism.
Groothuis PG; De Gooyer ME; ten Kate J; Menheere PP; Dunselman GA; de Goeij AF; Verbost P; Ederveen AG; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):152-60. PubMed ID: 16781141
[TBL] [Abstract][Full Text] [Related]
7. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
8. Progestagenic effects of tibolone are target gene-specific in human endometrial cells.
Zhang W; Mazella J; Kloosterboer HJ; Tseng L
J Soc Gynecol Investig; 2006 Sep; 13(6):459-65. PubMed ID: 16879988
[TBL] [Abstract][Full Text] [Related]
9. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
10. Tissue-selectivity: the mechanism of action of tibolone.
Kloosterboer HJ
Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
[TBL] [Abstract][Full Text] [Related]
11. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
12. Tissue-selective effects of tibolone on the breast.
Kloosterboer HJ
Maturitas; 2004 Sep; 49(1):S5-S15. PubMed ID: 15351102
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
